Jason Rasmussen, MD
Surgery · Minneapolis, MNNPI 1033191200
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $59,143 of the $60,400 with a category attached, or 97.9%. Organogenesis Inc. accounts for 99.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $59,543 and has fallen 100.0% since, to $11 in 2024. Among surgery clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 169 payments — averaging $357.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$60K
- Bioventus LLC$15
- Smith+Nephew$14
- Kerecis Limited$11
What the payments were for
- Speaking & faculty fees$59,14398%
- Travel & lodging$8761%
- Food & beverage$3821%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 166 | $60,361 |
| Bioventus LLC | 1 | $15 |
| Smith+Nephew | 1 | $14 |
| Kerecis Limited | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Apligraf$56,512
- Dermagraft$56,512
- Puraply/Affinity/NuTech$56,512
- PuraPly$800
- PuraPly AM$113
How this compares
$60,400 in reported general payments places this provider in the 95th percentile of 498 surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 42 | $1,037 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 34 | $460 |
| Triamcinolone Acetonide | 27 | $298 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $178 |
Paid to pharmacies, not to this prescriber.
Other surgery in Minneapolis
- Charles SvendsenMinneapolis$266K
- Michael MegalyMinneapolis$168K
- Raja KandaswamyMinneapolis$100K
- Christopher MacomberMinneapolis$55K
- Timothy SielaffMinneapolis$33K
- Joseph CarrollMinneapolis$25K
- Joseph van CampMinneapolis$22K
- Eric WiseMinneapolis$20K
- John McCormick-DeatonMinneapolis$19K
- Cyrus JahansouzMinneapolis$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.